These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23101190)

  • 1. Anaphylaxis to vapors of roasting chicken controlled by omalizumab.
    Barnig C; Hilger C; Muti D; Blaumeiser M; Purohit A; Hentges F; de Blay F
    J Investig Allergol Clin Immunol; 2012; 22(6):439-40. PubMed ID: 23101190
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of omalizumab in the treatment of food allergy and anaphylaxis.
    Lieberman JA; Chehade M
    Curr Allergy Asthma Rep; 2013 Feb; 13(1):78-84. PubMed ID: 23065311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dupilumab for treatment of food allergy.
    Rial MJ; Barroso B; Sastre J
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):673-674. PubMed ID: 30075339
    [No Abstract]   [Full Text] [Related]  

  • 4. Omalizumab induced remission of idiopathic anaphylaxis in a patient suffering from indolent systemic mastocytosis.
    Kibsgaard L; Skjold T; Deleuran M; Vestergaard C
    Acta Derm Venereol; 2014 May; 94(3):363-4. PubMed ID: 24162824
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-IgE--emerging opportunities for Omalizumab.
    Babu KS; Polosa R; Morjaria JB
    Expert Opin Biol Ther; 2013 May; 13(5):765-77. PubMed ID: 23517576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omalizumab and hypersensitivity reactions.
    Shankar T; Petrov AA
    Curr Opin Allergy Clin Immunol; 2013 Feb; 13(1):19-24. PubMed ID: 23242113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of omalizumab in patients with food allergy.
    Rafi A; Do LT; Katz R; Sheinkopf LE; Simons CW; Klaustermeyer W
    Allergy Asthma Proc; 2010; 31(1):76-83. PubMed ID: 20167148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution in immunological methods used in research and in the clinical diagnosis and management of human allergic diseases.
    Hamilton RG
    J Immunol Methods; 2012 Sep; 383(1-2):1-3. PubMed ID: 22750249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A patient with steroids and antihistaminic drug allergy and newly occurred chronic urticaria angioedema: what about omalizumab?
    Kutlu A; Karabacak E; Aydin E; Ozturk S; Bozkurt B
    Hum Exp Toxicol; 2014 Aug; 33(8):882-5. PubMed ID: 24203455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab for the Treatment of Multiple Food Allergies. Reply.
    Wood RA; Togias A; Chinthrajah RS
    N Engl J Med; 2024 May; 390(20):1936. PubMed ID: 38810198
    [No Abstract]   [Full Text] [Related]  

  • 11. Omalizumab for the Treatment of Multiple Food Allergies.
    Hui Shi En E; Cheng-Chung Wei J
    N Engl J Med; 2024 May; 390(20):1936. PubMed ID: 38810197
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of severe asthma and peach allergy that improved with omalizumab therapy: a case report].
    Suzuki S; Matsuura T; Kimura T; Tazaki T; Fukuda M; Homma T; Matsukura S; Kurokawa M; Adachi M
    Arerugi; 2012 Feb; 61(2):215-23. PubMed ID: 22437731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of mastocytic anaphylactic episodes with reduction of skin mast cells after anti-IgE therapy.
    Paraskevopoulos G; Sifnaios E; Christodoulopoulos K; Mantopoulou F; Papakonstantis M; Sabaziotis D
    Eur Ann Allergy Clin Immunol; 2013 Apr; 45(2):52-5. PubMed ID: 23821833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omalizumab effectively prevents recurrent refractory anaphylaxis in a patient with monoclonal mast cell activation syndrome.
    Jagdis A; Vadas P
    Ann Allergy Asthma Immunol; 2014 Jul; 113(1):115-6. PubMed ID: 24950847
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential treatments for food allergy.
    Albin S; Nowak-Węgrzyn A
    Immunol Allergy Clin North Am; 2015 Feb; 35(1):77-100. PubMed ID: 25459578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omalizumab mitigates anaphylaxis during ultrarush honey bee venom immunotherapy in monoclonal mast cell activation syndrome.
    da Silva EN; Randall KL
    J Allergy Clin Immunol Pract; 2013; 1(6):687-8. PubMed ID: 24565720
    [No Abstract]   [Full Text] [Related]  

  • 17. A critical appraisal of omalizumab as a therapeutic option for chronic refractory urticaria/angioedema.
    Lang DM
    Ann Allergy Asthma Immunol; 2014 Apr; 112(4):276-9. PubMed ID: 24589165
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-IgE (omalizumab) inhibits late-phase reactions and inflammatory cells after repeat skin allergen challenge.
    Ong YE; Menzies-Gow A; Barkans J; Benyahia F; Ou TT; Ying S; Kay AB
    J Allergy Clin Immunol; 2005 Sep; 116(3):558-64. PubMed ID: 16159624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omalizumab in idiopathic anaphylaxis.
    Warrier P; Casale TB
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):257-8. PubMed ID: 19354075
    [No Abstract]   [Full Text] [Related]  

  • 20. Broad Bean-Induced Anaphylaxis: A Case Report.
    Rodríguez-Mazariego ME; Fuentes Aparicio V; Bartolomé Zavala B; Acevedo Matos M; Zapatero Remón L
    J Investig Allergol Clin Immunol; 2016; 26(6):374-375. PubMed ID: 27996944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.